BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26372304)

  • 1. Metabolic consequences of polycystic ovary syndrome.
    Churchill SJ; Wang ET; Pisarska MD
    Minerva Ginecol; 2015 Dec; 67(6):545-55. PubMed ID: 26372304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New paradigms in PCOS: impaired glucose tolerance and cardiovascular risk. Clinical approach.
    Ravn P
    Minerva Ginecol; 2015 Apr; 67(2):217-23. PubMed ID: 25668421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term consequences of polycystic ovary syndrome].
    Grigoryan OR; Zhemaite NS; Volevodz NN; Andreeva EN; Melnichenko GA; Dedov II
    Ter Arkh; 2017; 89(10):75-79. PubMed ID: 29171475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG Practice Bulletin No. 194 Summary: Polycystic Ovary Syndrome.
    Obstet Gynecol; 2018 Jun; 131(6):1174-1176. PubMed ID: 29794670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovaries - beyond menopause.
    Shah D; Bansal S
    Climacteric; 2014 Apr; 17(2):109-15. PubMed ID: 23895379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome and metabolic syndrome.
    Ali AT
    Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
    Cussons AJ; Stuckey BG; Watts GF
    Atherosclerosis; 2006 Apr; 185(2):227-39. PubMed ID: 16313910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.
    Wiltgen D; Spritzer PM
    Fertil Steril; 2010 Nov; 94(6):2493-6. PubMed ID: 20338557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
    Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
    Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome and female reproduction.
    Elghblawi E
    Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical cardiovascular disease and polycystic ovary syndrome.
    Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
    Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.
    American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology
    Obstet Gynecol; 2018 Jun; 131(6):e157-e171. PubMed ID: 29794677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.
    Martikainen H; Ruokonen A; Hartikainen AL; Järvelin MR
    Int J Circumpolar Health; 1998 Jul; 57(2-3):133-7. PubMed ID: 9753881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not all women diagnosed with PCOS share the same cardiovascular risk profiles.
    Jovanovic VP; Carmina E; Lobo RA
    Fertil Steril; 2010 Aug; 94(3):826-32. PubMed ID: 19501355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.